BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9488384)

  • 1. Immunoglobulins to group A streptococcal surface molecules decrease adherence to and invasion of human pharyngeal cells.
    Fluckiger U; Jones KF; Fischetti VA
    Infect Immun; 1998 Mar; 66(3):974-9. PubMed ID: 9488384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulins inhibit adherence and internalization of Streptococcus pyogenes to human pharyngeal cells.
    Fluckiger U; Fischetti VA
    Adv Exp Med Biol; 1997; 418():909-11. PubMed ID: 9331796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group A streptococci bind to mucin and human pharyngeal cells through sialic acid-containing receptors.
    Ryan PA; Pancholi V; Fischetti VA
    Infect Immun; 2001 Dec; 69(12):7402-12. PubMed ID: 11705914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.
    Bessen D; Fischetti VA
    J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities.
    Brandt ER; Hayman WA; Currie B; Carapetis J; Jackson DC; Do KA; Good MF
    Int Immunol; 1999 Apr; 11(4):569-76. PubMed ID: 10323210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretory IgA and bacterial adherence to nasal mucosal cells.
    Kurono Y; Fujiyoshi T; Mogi G
    Ann Otol Rhinol Laryngol; 1989 Apr; 98(4 Pt 1):273-7. PubMed ID: 2650595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased serum and pharyngeal antibody levels specific to streptococcal lipoteichoic acid in children with recurrent tonsillitis.
    Yokoyama Y; Harabuchi Y
    Int J Pediatr Otorhinolaryngol; 2002 May; 63(3):199-207. PubMed ID: 11997155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive protection of mice against group A streptococcal pharyngeal infection by lipoteichoic acid.
    Dale JB; Baird RW; Courtney HS; Hasty DL; Bronze MS
    J Infect Dis; 1994 Feb; 169(2):319-23. PubMed ID: 8106764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci.
    Bessen D; Fischetti VA
    Infect Immun; 1988 Oct; 56(10):2666-72. PubMed ID: 2458320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ability of clinical isolates of group A streptococci to adhere to and invade HEp-2 epithelial cells.
    Bennett-Wood VR; Carapetis JR; Robins-Browne RM
    J Med Microbiol; 1998 Oct; 47(10):899-906. PubMed ID: 9788814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes.
    Mannam P; Jones KF; Geller BL
    Infect Immun; 2004 Jun; 72(6):3444-50. PubMed ID: 15155651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal immunization with lipoteichoic acid and cholera toxin evokes specific pharyngeal IgA and systemic IgG responses and inhibits streptococcal adherence to pharyngeal epithelial cells in mice.
    Yokoyama Y; Harabuchi Y
    Int J Pediatr Otorhinolaryngol; 2002 May; 63(3):235-41. PubMed ID: 11997159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human secretory immune response to streptococcal M protein. Identification of a secretory IgA epitope in the exposed conserved region.
    Yoshinaga M; Miyata K; Fischetti VA
    Adv Exp Med Biol; 1997; 418():913-5. PubMed ID: 9331797
    [No Abstract]   [Full Text] [Related]  

  • 14. Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A.
    Bessen D; Fischetti VA
    J Exp Med; 1988 Jun; 167(6):1945-50. PubMed ID: 3290383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections.
    Basma H; Norrby-Teglund A; McGeer A; Low DE; El-Ahmedy O; Dale JB; Schwartz B; Kotb M
    Infect Immun; 1998 May; 66(5):2279-83. PubMed ID: 9573118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against streptococcal pharyngeal colonization with a vaccinia: M protein recombinant.
    Fischetti VA; Hodges WM; Hruby DE
    Science; 1989 Jun; 244(4911):1487-90. PubMed ID: 2660266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of M protein in adherence of group A streptococci.
    Caparon MG; Stephens DS; Olsén A; Scott JR
    Infect Immun; 1991 May; 59(5):1811-7. PubMed ID: 2019444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological and immunochemical identity of M protein on group G streptococci with M protein on group A streptococci.
    Jones KF; Fischetti VA
    Infect Immun; 1987 Mar; 55(3):502-6. PubMed ID: 3546129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of M protein in pharyngeal colonization by group A streptococci in rats.
    Hollingshead SK; Simecka JW; Michalek SM
    Infect Immun; 1993 Jun; 61(6):2277-83. PubMed ID: 8500869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M protein mediates streptococcal adhesion to HEp-2 cells.
    Wang JR; Stinson MW
    Infect Immun; 1994 Feb; 62(2):442-8. PubMed ID: 8300205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.